Estrone sulfatase versus estrone sulfotransferase in human breast cancer: Potential clinical applications

Journal of Steroid Biochemistry and Molecular Biology

Volumn 69, Issue 1-6, 1999, Pages 287-292

  Pasqualini, J R ^a   Chetrite, G S ^a  

^a Hormones and Cancer Research Unit   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTRONE SULFATE; MEDROGESTONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NOMEGESTROL ACETATE; PROGESTERONE DERIVATIVE; PROMEGESTONE; SULFATASE; SULFOTRANSFERASE; TIBOLONE;

BREAST CANCER; CONFERENCE PAPER; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ESTROGEN SYNTHESIS; HUMAN; POSTMENOPAUSE; PROTEIN DEGRADATION;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; SULFATASES; SULFOTRANSFERASES;

EID: 0032977320     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00082-5     Document Type: Conference Paper

References (64)

1. Segaloff A. Hormones and mammary carcinogenesis. McGuire W.L. Breast Cancer 2: Advances in Research and Treatment, Experimental Biology. 1978;1-22 Plenum Press, New York.
2. Kirschner M.A. The role of hormones in the development of human breast cancer. McGuire W.L. Breast Cancer 3: Advances in Research and Treatment, Current Topics. 1979;199-226 Plenum Press, New York.
3. Lippman M.E., Dickson R.B., Bates S., Knabbe C., Huff K., Swain S., McManaway M., Bronzert D., Kasid A., Gelmann E.P. Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat. 7:1986;59-70.
4. Henderson B.E., Ross R., Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award lecture. Cancer Res. 48:1988;246-253.
5. Pasqualini J.R., Chetrite G., Blacker C., Feinstein M.-C, Delalonde L., Talbi M., Maloche C. Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer. J. Clin. Endocr. Metab. 81:1996;1460-1464.
6. Pasqualini J.R., Cortes-Prieto J., Chetrite G., Talbi M., Ruiz A. Concentrations of estrone, estradiol, and their sulfates and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Int. J. Cancer. 70:1997;639-643.
7. van Landeghem A.A.J., Poortman J., Nabuurs M., Thijssen J.H.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 45:1985;2900-2906.
8. Vermeulen A., Deslypere J.P., Paridaens R., Leclercq G., Roy F., Heuson J.C. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol. 22:1986;515-525.
9. Labrie F. Intracrinology. Molec. Cell. Endocr. 78:1991;C113-C118.
10. Abul-Hajj Y.J., Iverson R., Kiang D.T. Aromatization of androgens by human breast cancer. Steroids. 33:1978;205-222.
11. Lipton A., Santner S.J., Santen R.J., Harvey H.A., Feil P.D., White-Hershey D., Bartholomew M.J., Antle C.E. Aromatase activity in primary and metastatic human breast cancer. Cancer. 59:1987;779-782.
12. Perel E., Wilkins D., Killinger D.W. The conversion of androstenedione to estrone, estradiol and testosterone in breast tissue. J. Steroid Biochem. 13:1980;89-94.
13. Dao T.L., Hayes C., Libby P.R. Steroid sulfatase activities in human breast tumors. Proc. Soc. Expl Biol. Med. 146:1974;381-384.
14. Pasqualini J.R., Gelly C., Lecerf F. Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 8:1986;233-240.
15. Pasqualini J.R., Gelly C., Nguyen B.-L., Vella C. Importance of estrogen sulfates in breast cancer. J. Steroid Biochem. 34:1989;155-163.
16. MacIndoe J.R., Woods G., Jeffries L., Hinkhouse M. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. Endocrinology. 123:1988;1281-1287.
17. Vignon F., Terqui M., Westley B., Derocq D., Rochefort H. Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology. 106:1980;1079-1086.
18. Abul-Hajj Y.J., Iverson R., Kiang D.T. Estradiol 17β-dehydrogenase and estradiol binding in human mammary tumors. Steroids. 33:1979;477-484.
19. 3H-oestradiol by normal breast and breast tumour tissues in postmenopausal women. Int. J. Cancer. 38:1986;193-196.
20. Bonney R.C., Reed M.J., Davidson K., Beranek P.A., James V.H.T. The relationship between 17β-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin. Endocr. 19:1983;727-739.
21. Santner S.J., Feil P.D., Santen R.J. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J. Clin. Endocr. Metab. 59:1984;29-33.
22. Tseng L., Mazella J., Lee L.Y., Stone M.L. Estrogen sulfatase and estrogen sulfotransferase in human primary mammary carcinoma. J. Steroid Biochem. 19:1983;1413-1417.
23. Dao T.L., Libby P.R. Conjugation of steroid hormones by normal and neoplastic tissues. J. Clin. Endocr. 28:1968;1431-1439.
24. Pasqualini J.R. Steroid sulphotransferase activity in human hormone-independent MDA-MB-468 mammary cancer cells. Eur. J. Cancer. 28A:1992;758-762.
25. Hobkirk R. Steroid sulfation: current concepts. Trends Endocr. Metab. 4:1993;69-74.
26. Chetrite G., Pasqualini J.R. Steroid sulphotransferase and 17β-hydroxysteroid dehydrogenase activities in Ishikawa human endometrial adenocarcinoma cells. J. Steroid Biochem. Molec. Biol. 61:1997;27-34.
27. Urabe M., Chetrite G., Pasqualini J.R. Transformation of estrone, estradiol and estrone sulfate in uterine and vaginal isolated cells of fetal guinea pig: effect of various antiestrogens in the conversion of estrone sulfate to estradiol. Steroids. 58:1993;209-214.
28. Noel C.T., Reed M.J., Jacobs H.S., James V.H.T. The plasma concentration of estrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J. Steroid Biochem. 14:1981;1101-1105.
29. Honjo H., Kitawaki J., Itoh M., Yasuda J., Iwasaku K., Urabe M., Naitoh K., Yamamoto T., Okada H., Ohkubo T., Nambara T. Serum and urinary estrone sulfate during the menstrual cycle, measured by a direct radioimmunoassay, and fate of exogenously injected estrone sulfate. Hormone Res. 27:1987;61-68.
30. Roberts K.D., Rochefort J.G., Bleau G., Chapdelaine A. Plasma estrone sulfate levels in postmenopausal women. Steroids. 35:1980;179-187.
31. Samojlik E., Santen and R.J., Worgul T.J. Plasma estrone sulfate assessment of reduced estrogen production during treatment of metastatic breast carcinoma. Steroids. 39:1982;496-507.
32. de Jong P.C., van de Ven J., Nortier H.W.R., Maitimu-Smeele I., Donker T.H., Thijssen J.H.H., Slee P.H.T.J., Blankenstein R.A. Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third-generation aromatase inhibitor Vorozole. Cancer Res. 57:1997;2109-2111.
33. Reed M.J., Lai L.C., Owen A.M., Singh A., Coldham N.G., Purohit A., Ghilchik M.W., Shaikh N.A., James V.H.T. Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer. Cancer Res. 50:1990;193-196.
34. Miller W.R. Aromatase inhibitors. Endocrine-Related Cancer. 3:1996;65-79.
35. Brodie A.M.H., Wing L.Y., Dowsett M., Goss P., Coombes R.C. Aromatase inhibitors and treatment of breast cancer. J. Steroid Biochem. 24:1986;91-97.
36. Prost-Avallet O., Oursin J., Adessi G.L. In vitro effect of synthetic progestogens on estrone sulfatase activity in human breast carcinoma. J. Steroid Biochem. Molec. Biol. 39:1991;967-973.
37. Whu B.T., Fu J.-H., Xu S., Kauffman F.C., Conney A.H. Different biochemical properties of nuclear and microsomal estrone-3-sulfatases: evidence for the presence of a nuclear isozyme. Biochem. Biophys. Res. Commun., 246:1998;45-49.
38. Pasqualini J.R., Schatz B., Varin C., Nguyen B.-L. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer. J. Steroid Biochem. Molec. Biol. 41:1992;323-329.
39. Pasqualini J.R., Chetrite G., Nguyen B.-L., Maloche M., Delalonde L., Talbi M., Feinstein M.-C., Blacker C., Botella J., Paris J. Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J. Steroid Biochem. Molec. Biol. 53:1995;407-412.
40. Pasqualini J.R., Maloche C., Maroni M., Chetrite G. Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Anticancer Res. 14:1994;1589-1594.
41. Pasqualini J.R., Gelly C., Lecerf F. Biological effects and morphological responses to estriol, estriol-3-sulfate, estriol-17-sulfate and tamoxifen in a tamoxifen-resistant cell line (R-27) derived from MCF-7 human breast cancer cells. Eur. J. Cancer Clin. Oncol. 22:1986;1495-1501.
42. Pasqualini J.R., Nguyen B.-L. Estrone sulfatase activity and effect of antiestrogens on transformation of estrone sulfate in hormone-dependent vs. independent human breast cancer cell lines. Breast Cancer Res. Treat. 18:1991;93-98.
43. Pasqualini J.R., Gelly C. Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone sulfate to estradiol in the MCF-7 mammary cancer cell line. Cancer Lett. 40:1988;115-121.
44. Santner S.J., Santen R.J. Inhibition of estrone sulfatase and 17β-hydroxysteroid dehydrogenase by antiestrogens. J. Steroid Biochem. Molec. Biol. 45:1993;383-390.
45. Chetrite G., Varin C., Delalonde and L., Pasqualini J.R. Effect of promegestone, tamoxifen, 4-hydroxytamoxifen and ICI 164,384 on the oestrone sulphatase activity of human breast cancer cells. Anticancer Res. 13:1993;931-934.
46. Chetrite G., Kloosterboer H.J., Pasqualini J.R. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res. 17:1997;135-140.
47. Chetrite G., Paris J., Botella and J., Pasqualini J.R. Effect of nomegestrol acetate on estrone-sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells. J. Steroid Biochem. Molec. Biol. 58:1996;525-531.
48. Pasqualini J.R., Varin C., Nguyen B.-L. Effect of the progestagen R-5020 (Promegestone) and of progesterone on the uptake and on the transformation of estrone sulfate in the MCF-7 and T-47D human mammary cancer cells: correlation with progesterone receptor levels. Cancer Lett. 66:1992;55-60.
49. G. Chetrite, C. Ebert, F. Wright, J.R. Pasqualini, Control of sulfatase and sulfotransferase activities by medrogestone in the hormone-dependent MCF-7 and T-47D human breast cancer cell lines, J. Steroid Biochem. Molec. Biol. (1999) 70 (in press).
50. A. Purohit, H.A.M. Hejaz, L.W.L. Woo, A.E. van Strien, B.V.L. Potter, M.J. Reed, Recent advances in the development of steroid sulphatase inhibitors, J. Steroid Biochem. Molec. Biol. (1999) 69 (in press).
51. Purohit A., Williams G.J., Howarth N.M., Potter B.V.L., Reed M.J. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-0-sulfamate. Biochemistry. 34:1995;11508-11514.
52. Purohit A., Williams G.J., Roberts C.J., Potter B.V.L., Reed M.J. In vivo inhibition of œstrone sulphatase and dehydroepiandrosterone sulphatase by œstrone-3-0-sulphamate. Int. J. Cancer. 62:1995;106-111.
53. Anderson E., Howell A. Oestrogen sulphotransferases in malignant and normal human breast tissue. Endocrine-Related Cancer. 2:1995;227-233.
54. Luu-The V., Bernier F., Dufort I. Steroid sulfotransferases. J. Endocr. 150:1996;S87-S97.
55. Strott C.A. Steroid sulfotransferases. Endocr. Rev. 17:1996;670-697.
56. Falany C.N., Wheeler J., Oh T.S., Falany J.L. Steroid sulfation by expressed human cytosolic sulfotransferases. J. Steroid Biochem. Molec. Biol. 48:1994;369-375.
57. Falany J.L., Falany C.N. Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res. 56:1996;1551-1555.
58. Adams J.B., Phillips N.S. Properties of estrogen and hydroxysteroid sulphotransferases in human mammary cancer. J. Steroid Biochem. 36:1990;695-701.
59. Komatsu K., Oeda and T., Strott C.A. Cloning and sequence analysis of the 5′-flanking region of the estrogen sulfotransferase gene: steroid response elements and cell-specific nuclear DNA-binding proteins. Biochem. Biophys. Res. Commun. 194:1993;1297-1304.
60. Adams J.B., Pewnim T., Chandra D.P., Archibald L., San Foo M. A correlation between estrogen sulfotransferase levels and estrogen receptor status in human primary breast carcinoma. Cancer Res. 39:1979;5124-5126.
61. Pewnim T., Adams J.B., Ho K.P. A relationship between estrogen sulfotransferase and estrogen and progesterone receptor status in human mammary carcinoma. Cancer Res. 40:1980;1360-1362.
62. Pewnim T., Adams J.B., Ho K.P. Estrogen sulfurylation as an alternative indicator of hormone dependence in human breast cancer. Steroids. 39:1982;47-52.
63. G.S. Chetrite, H.J. Kloosterboer, J.-C. Philippe, J.R. Pasqualini, Effect of Org OD14 (Livial®) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231 breast cancer cell lines, Anticancer Res. 19 (1999) 269-276.
64. Chetrite G., Le Nestour E., Pasqualini J.R. Human estrogen sulfotransferase (hEST1) activities and its mRNA in various breast cancer cell lines: effect of the progestin, promegestone (R-5020). J. Steroid Biochem. Molec. Biol. 66:1998;295-302.